Skip to main content
SpringerLink
Log in

Potential Therapeutics of Vitamin E (Tocopherol) in AIDS and HIV

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Berkelman RL, Heyward WL, Stehr-Green JK, et al. Epidemiology of human immunodeficiency virus infection and acquired immunodeficiency syndrome. Am J Med 1989; 86: 761–6

    PubMed  CAS  Google Scholar 

  2. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993; 262: 1011–3

    PubMed  CAS  Google Scholar 

  3. Coodley G, Girard DE. Vitamins and minerals in HIV infection. J General Intern Med 1991; 6: 472–9

    CAS  Google Scholar 

  4. Chlehowski RT. Significance of altered nutritional status in acquired immune deficiency syndrome (AIDS). Nutr Cancer 1985; 7: 85–90

    Google Scholar 

  5. Koenig S, Fauci AS. AIDS: etiology, diagnosis, treatment and prevention. In: Devita VT, Hellman S, Rosenberg SA, editors. New York: JB Lippincott Co., 1990; 61-72

  6. Bowen DL, Lane HC, Fauci AS. Immunopathogenesis of the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 704–12

    PubMed  CAS  Google Scholar 

  7. Baruchel S, Weinberg MA. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leuk Biol 1992; 52: 111–4

    CAS  Google Scholar 

  8. Kayden HJ, Chow C, Bjornson LK. Spectrophometric method for determination of tocopherol in red blood cells. J Lipid Res 1973; 14: 533–40

    PubMed  CAS  Google Scholar 

  9. Burton GW, Traber MG. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Ann Rev Nutr 1990; 10: 357–82

    CAS  Google Scholar 

  10. Packer L. Protective role of vitamin E in biological systems. Am J Clin Nutr 1991; 53: 1050s–5s

    PubMed  CAS  Google Scholar 

  11. Arai K, Lee F, Miyajima A, et al. Cytokines: coordinates of immune and inflammatory responses. Ann Rev Biochem 1990; 59: 783–836

    PubMed  CAS  Google Scholar 

  12. Balkwill FR, Burke F. The cytokine network. Immunol Today 1989: 299-302

  13. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T-cells. Adv Immunol 1989; 46: 11–9

    Google Scholar 

  14. Mosmann TR, Morre KW. The role of IL-10 in crossregulation of Th1 and Th2 responses. Immunoparasitol Today 1991; A49-A54

  15. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th1 clones. J Immunol 1987; 138: 3688–97

    CAS  Google Scholar 

  16. Sanpper CM, Finkelman FD, Paul WE. Regulation of IgG1 and IgE production by interleukin-4. Immunol Rev 1988; 102: 51–63

    Google Scholar 

  17. Clerici M, Shearer GM. A Th1 → Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 107–10

    PubMed  CAS  Google Scholar 

  18. Bradley WG, Ogata N, Good RA, et al. Alteration of in vivo cytokine gene expression in mice infected with a molecular clone the defective MAIDS virus. J AIDS 1993; 7: 1–10

    CAS  Google Scholar 

  19. Wang Y, Huang DS, Giger PT, et al. The kinetics of imbalanced cytokine production by T cells and macrophages during the murine AIDS. Adv Biosci 1993; 86: 335–39

    CAS  Google Scholar 

  20. Gazzinelli RT, Makino M, Chattopadhyay SK, et al. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol 1992; 148: 182–91

    PubMed  CAS  Google Scholar 

  21. Watson RR. Minireview of murine models for acquired immune deficiency syndrome. Life Sci 1989; 44: 3–4

    Google Scholar 

  22. Kanagawa O, Vaupel BA, Gayama S, et al. Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science 1993; 262: 240–2

    PubMed  CAS  Google Scholar 

  23. Wang Y, Ardestani SK, Liang B, et al. Administration of interferon-λ and monoclonal anti-interleukin-4 retards development of immune dysfunction and cytokine dysregulation during murine AIDS. Immunology. In press

  24. Wang Y, Huang DS, Eskelson C, et al. Long term dietary vitamin E retards cytokine dysregulation by splenocytes during murine AIDS caused by LP-BM5 retrovirus infection. Immunol Immunopath. In press

  25. Wang Y, Huang DS, Liang B, et al. Nutritional status and immune functions are normalised by vitamin E supplementation in murine AIDS. J Nutr 1994. In press

  26. Bertoglio JH, Leroux E. Differential effects of glucocorticoid on the proliferation of a murine helper and a cytolytic T cell clone in response to IL-2 and IL-4. J Immunol 1988; 141: 1191–6

    PubMed  CAS  Google Scholar 

  27. Gills S, Crabtree GR, Smith KA. Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 1979; 123: 1624–31

    Google Scholar 

  28. Daynes RA, Araneo, BA. Contrasting effects of glucocorticoid on the capacity of T cells to produce the growth factors inter-leukin 2 and interleukin 4. Eur J Immunol 1989; 19: 2319–25

    PubMed  CAS  Google Scholar 

  29. Daynes RA, Dudley DJ, Araneo BA. Regulation of murine lymphokine production in vivo. II. Dihydroepiandrosterone is a natural enhancer of IL-2 synthesis in helper T cells. Eur J Immunol 1990; 20: 793–802

    CAS  Google Scholar 

  30. Lim TS, Putt N, Satranski D, et al. Effect of vitamin E on cell-mediated immune responses and serum corticosterone in young and maturing mice. Immunology 1981; 44: 289–95

    PubMed  CAS  Google Scholar 

  31. Coodley GO, Loveless MO, Heidi D, et al. Endocrine function in the HIV wasting syndrome. J AIDS 1994; 7: 46–51

    CAS  Google Scholar 

  32. Fauci AS, Dale DC. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest 1974; 53: 240–6

    PubMed  CAS  Google Scholar 

  33. Chouaib S, Weite K, Mertelsmann R, et al. PGE2 acts at two distinct pathways of T lymphocyte activation: inhibition of IL-2 production and downregulation of transferrin expression. J Immunol 1985; 135: 1172–9

    PubMed  CAS  Google Scholar 

  34. Feldman RD, Hunninghake GW, Mcardle WL. β-Adrenergic receptor-mediated suppression of IL-2 receptor in human lymphocytes. J Immunol 1987; 139: 3355–9

    PubMed  CAS  Google Scholar 

  35. Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphocytes but no of Th2 lymphokines. J Immunol 1991; 146: 108–13

    PubMed  CAS  Google Scholar 

  36. Fernandes G, Tomar V, Mohan N et al. Potential of diet therapy on murine AIDS. J Nutr 1992; 122: 716–22

    PubMed  CAS  Google Scholar 

  37. Meydani SN, Meydani M, Verdon CP, et al. Vitamin E supplementation suppresses PGE2 synthesis and enhances the immune response of ages mice. Mech Ageing Dev 1986; 12: 191–201

    Google Scholar 

  38. Boue F, Wallon C, Goujard C, et al. HIV induced IL-6 production by human B lymphocytes: role of IL-4. J Immunol 1992; 148: 3761–87

    PubMed  CAS  Google Scholar 

  39. Van Snick J. Interleukin-6: an overview. Ann Rev Immunol 1990; 8: 253–78

    Google Scholar 

  40. Grunfeld C, Ferngold KR. The role of the cytokines, interferon alpha and tumor necrosis factor in the hypertriglyceridemia and wasting of AIDS. J Nutr 1992; 122: 749–53

    PubMed  CAS  Google Scholar 

  41. Odeleye OE, Eskelson CD, Watson, RR. Changes in hepatic lipid composition after infection by LP-BM5 causing murine AIDS. Life Sci 1992; 51: 129–34

    PubMed  CAS  Google Scholar 

  42. Mellors JW, Griffith BP, Ortiz MA, et al. Tumor necrosis fac-tor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis 1991; 163: 78–82

    PubMed  CAS  Google Scholar 

  43. Poli G, Bressler P, Kinter A. Interleukin 6 induces human immunodeficiency virus expression in monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanism. J Exp Med 1990; 172: 151–8

    PubMed  CAS  Google Scholar 

  44. Odeleye OE, Eskelson CD, Mufti SI, et al. Vitamin E protection against chemically-induced esophageal tumor growth in mice immunocompromised by retroviral infection. Carcinogenesis 1992; 13: 1811–6

    PubMed  CAS  Google Scholar 

  45. Lanzavecchia A, Roosnek E, Gregory T, et al. T cells present antigens such as HIV gp120 targeted to their own surface molecules. Nature 1988; 334: 530–3

    PubMed  CAS  Google Scholar 

  46. McCune JM. HIV-1: the infective process in vivo. Cell 1991; 64: 351–64

    PubMed  CAS  Google Scholar 

  47. Odeleye OE, Watson RR. The potential role of vitamin E in the treatment of immunological abnormalities during acquired immune deficiency syndrome. Prog Food Nutr Sci 1991; 15: 1–19

    PubMed  CAS  Google Scholar 

  48. Meydani SN, Meyani M, Blumberg JB. Antioxidants and the aging immune response. Adv Exp Med Biol 1990; 262: 57–67

    PubMed  CAS  Google Scholar 

  49. Meydani SN, Barklund MP, Liu S, et al. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr 1990; 52: 557–63

    PubMed  CAS  Google Scholar 

  50. Watson RR, Moriguchi S, Jackson J, et al. Modification of cellular immune functions in humans by endurance excise training during β-adrenergic blockade with atenolol or propranolol. Med Sci Sport Exercise 1986; 18: 95–100

    CAS  Google Scholar 

  51. Shefty B, Schultz R. Influence of vitamin E and selenium on immune response mechanisms. Fed Proc 1979; 38: 2139–43

    Google Scholar 

  52. Taccone-Galluci M, Giardini D, Piazza A, et al. Vitamin E supplementation in hemodialysis patients: effects on peripheral blood mononuclear cell lipids peroxidation and immune response. Clin Nephrol 1986; 25: 81–6

    Google Scholar 

  53. Prasad JN. Effect of vitamin E supplementation on leukocyte function. Am J Clin Nutr 1980; 33: 606–8

    PubMed  CAS  Google Scholar 

  54. Bendich A. Antioxidant vitamins and their functions in immune responses. Adv Exp Med Biol 1990; 262: 35–55

    PubMed  CAS  Google Scholar 

  55. Kline K, Rao A, Romach EH, et al. Vitamin E modulation of disease resistance and immune responses. Ann NY Acad Sci 1990; 587: 294–6

    Google Scholar 

  56. Meydani SN, Meydani M, Verdon CP, et al. Vitamin E supplementation suppresses prostaglandin E2 synthesis and enhances the immune response of aged mice. Mech Aging Dev 1986; 34: 191–201

    PubMed  CAS  Google Scholar 

  57. Welsh A. Lupus erythematosus: treatment by combined use of massive amounts of calcium pantothenate with synthetic vitamin E. SO-A.M.A. Arch Dermat Syph 1952; 65: 137–48

    CAS  Google Scholar 

  58. Staltman P. Oxidative stress: a radical view. Semin Hematol 1989; 26: 249–56

    Google Scholar 

  59. Baruchel S, Weinberg MA. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leuk Biol 1992; 52: 111–4

    CAS  Google Scholar 

  60. Eck HP, Gmunder H, Hartmann M, et al. Low concentration of acid-soluble thiol (cystine) in the blood plasma of HIV-1 infected patients. Biol Chem Hoppe-Seyler, 1989; 370: 101–8

    PubMed  CAS  Google Scholar 

  61. Kalebic T, Kinter A, Poli G, et al. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetyl-L-cysteine. Proc Natl Acad Sci USA 1990; 88: 986–90

    Google Scholar 

  62. Staal FJT, Roederer M, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kB and transcription of HIV. Proc Natl Acad Sci USA, 1990; 87: 9943–7

    PubMed  CAS  Google Scholar 

  63. Floyd RA, Schneider JE. Hydroxy free radicals damage to DNA. In: Vigo-Pelfrey C, editor. Membrane lipid oxidation. Boca Raton: CRC Press, 1989; I: 245–37

    Google Scholar 

  64. Halliwell B, Gutterbridge JMC. The importance of free radicals and catalytic metal ions in human disease. Mol Aspects Med 1985; 8: 189–93

    Google Scholar 

  65. Suthanthiran M, Anderson ME, Sharma VK, et al. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci USA 1990; 87: 3343–7

    PubMed  CAS  Google Scholar 

  66. Buhl R, Jaffe HA, Holroyd KJ, et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989; 2: 1294–8

    PubMed  CAS  Google Scholar 

  67. Roederer M, Stall FJ, Raju PA, et al. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci USA, 1990; 87: 4884–8

    PubMed  CAS  Google Scholar 

  68. Klebanoff SJ, Vadas MA, Harlan JM, et al. Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986; 136: 4220–5

    PubMed  CAS  Google Scholar 

  69. Paeck R, Rubin, P, Bauerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV. EMBO J 1991; 10: 2247–58

    Google Scholar 

  70. Toledano M, Leonard W. Modulation of transcription factor NF-kB by oxidation-reduction in vitro. Proc Natl Acad Sci USA, 1991; 88: 4328–32

    PubMed  CAS  Google Scholar 

  71. Rabinovitch A, Baquerizo H, Sumoski W. Cytotoxic effects of cytokines on islet beta-cells: evidence for involvement of eicosanoids. Endocrinology 1990; 126: 67–71

    PubMed  CAS  Google Scholar 

  72. Spriggs DR, Sherman ML, Imamura K, et al. Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor. Cancer Res 1990; 50: 7101–7

    PubMed  CAS  Google Scholar 

  73. Akama H, Ichikawa Y, Matsushita Y, et al. Mononuclear cells enhance prostaglandin E2 production of polymorphonuclear leukocytes via tumor necrosis factor-α. Biochem Biophys Res Commun 1990; 168: 857–62

    PubMed  CAS  Google Scholar 

  74. Gogu SR, Beckman BS, Rangan SR, et al. Increased therapeutic efficacy of zidovudine in combination with vitamin E. Biochem Biophys Res Commun 1989; 165: 401–7

    PubMed  CAS  Google Scholar 

  75. Hishinuma I, Nakamura T. Alpha-tocopherol and inhibition of cytolysis in glutathione-depleted hepatocytes in primary culture. J Nutr Sci Vitaminol (Tokyo) 1988; 34: 11–23

    CAS  Google Scholar 

  76. Leedle RA, Aust DS. The effect of glutathione on the vitamin E requirement for inhibition of liver microsomal lipid peroxidation. Lipids 1990; 25: 241–5

    PubMed  CAS  Google Scholar 

  77. Pascoe GA, Olafsdottir K, Reed DJ, Vitamin Eprotection against chemical-induced cell injury. I. Maintenance of cellular protein thiols as a cytoprotective mechanism. Arch Biochem Biophys 1987; 256: 150–8

    CAS  Google Scholar 

  78. Boxer LA, Oliver JM, Spielberg SP, et al. Protection of granulocytes by vitamin E in glutathione synthetase deficiency. N Engl J Med 1979; 301: 901–5

    PubMed  CAS  Google Scholar 

  79. Corash LM, Sheetz, M, Bieri JG, et al. Chronic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency or glutathione synthetase deficiency: the role vitamin E in its treatment. Ann NY Acad Sci 1982; 393: 348–60

    PubMed  CAS  Google Scholar 

  80. Sundstrom H, Korpela H, Sajanti E, et al. Supplementation with selenium, vitamin E and their combination in gynecological cancer during cytotoxic chemotherapy. Carcinogenesis 1989; 10: 273–8

    PubMed  CAS  Google Scholar 

  81. Costagliola C, Menzione M. Effect of vitamin E on the oxidative state of glutathione in plasma. Clin Physiol Biochem 1990; 8: 140–3

    PubMed  CAS  Google Scholar 

  82. Mezes M, Par A, Bartosiewicz G, et al. Vitamin E content and lipid peroxidation of blood in some chronic inflammatory diseases. Acta Physiol Hung 1987; 69: 133–8

    PubMed  CAS  Google Scholar 

  83. Mezes M, Par A, Nemeth P, et al. Studies of the blood lipid peroxide status and vitamin E levels in patients with chronic active hepatitis and alcohol liver disease. Int J Clin Pharmacol Res 1986; 6: 333–8

    PubMed  CAS  Google Scholar 

  84. Vinogradova LF, Mirzoian ZhA, Kharlitskaia EV, et al. Experimental antioxidant therapy in toxic liver damage from CCl4 and chloxyl. Patol Fiziol Eksp Ter 1989; 12: 52–6

    Google Scholar 

  85. Vinogradova LF, Kharlitskaia EV, Mirzoian ZhA, et al. Antioxidant activity of ubiquinone-9 and its combinations with vitamin E and sodium selenite in toxic lesions of the liver. Farmakol Toksikol 1989; 52: 53–6

    PubMed  CAS  Google Scholar 

  86. Sclafani L, Shimm P, Edelman J, et al. Protective effect of vitamin E in rats with acute liver injury. J Parenter Enteral Nutr 1986; 10: 184–7

    CAS  Google Scholar 

  87. Fariss MW, Merson MH, O’Hara TM. Alpha-tocopherol succinate protects hepatocytes from chemical-induced toxicity under physiological calcium conditions. Toxicol Lett 1989; 47: 61–75

    PubMed  CAS  Google Scholar 

  88. Pascoe GA, Reed DJ. Vitamin E protection against chemical-induced cell injury. II. Evidence for a threshold effect of cellular alpha-tocopherol in prevention of adriamycin toxicity. Arch Biochem Biophys 1987; 256: 159–66

    CAS  Google Scholar 

  89. Pascoe GA, Reed DJ. Relationship between cellular calcium and vitamin E metabolism during protection against cell injury. Arch Biochem Biophys 1987; 253: 287–96

    PubMed  CAS  Google Scholar 

  90. Carini R. Poli G, Dianzani MU, et al. Comparative evaluation of the antioxidant activity of alpha-tocopherol, alpha-tocopherol polyethylene glycol 1000 succinate and alpha-tocopherol succinate in isolate hepatocytes and liver microsomal suspensions. Biochem Pharmacol 1990; 39: 1579–601

    Google Scholar 

  91. Chandra RK, Scrimshaw WS. Immunocompetence in nutritional assessment. Am J Clin Nutr 1980; 33: 2694–8

    PubMed  CAS  Google Scholar 

  92. Chandra RK. Nutrition, immunity and infections: present knowledge and future directions. Lancet 1983; 1: 688–91

    PubMed  CAS  Google Scholar 

  93. Dorsetor J, Whittle HC, Granwood BM. Persistent measles infection in malnourished children. BMJ 1977; 2: 1633–55

    Google Scholar 

  94. Grunt JP. Clinical impact of protein malnutrition on organ mass and functions. In: Blackhur GL, Grant JP, Young VP, editors. Amino acid metabolism and medical applications. Boston: Wright, 1977; 347-58

  95. Dworkin BM, Wormser GP, Axelrod R. Dietary intake in patients with acquired immunodeficiency syndrome (AIDS), patients with AIDS-related complex and serologically positive human immunodeficiency virus patients: correlations with nutritional status. J Par Ent Nutr 1990; 14: 605–12

    CAS  Google Scholar 

  96. Coodley G, Girard DE. Vitamins and minerals in HIV infection. J General Intern Med 1991; 6: 472–9

    CAS  Google Scholar 

  97. Beach RS, Mantero-Atienza E, Eisdorfer C, et al. Altered folate metabolism in early HIV infection. JAMA 1988; 259: 3129–33

    Google Scholar 

  98. Harriman G, Smith PD, Home MK, et al. Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch Intern Med 1989; 149: 2039–41

    PubMed  CAS  Google Scholar 

  99. Remacha A. Acquired immune deficiency syndrome and vitamin B12. Eur J Haematol 1989; 42: 506–10

    PubMed  CAS  Google Scholar 

  100. Bogden JD, Baker H, Frank O. et al. Micronutrient status and human immunodeficiency virus (HIV) infection. Ann NY Acad Sci 1990; 587: 189–92

    CAS  Google Scholar 

  101. Passi S, De Luca C, Oicardo M, et al. Blood deficiency values of polyunsaturated fatty acids of phospholipids, vitamin E and glutathione peroxidase as possible risk factors in the onset and development of acquired immunodeficiency syndrome. G Ital Dermoatol Venereol 1989; 125: 125–37

    Google Scholar 

  102. Falut J, Tsoukas C, Gold P. Zinc as a cofactor in human immunodeficiency virus-induced immunosuppression. JAMA 1988; 259: 2850–1

    Google Scholar 

  103. Coulston A, McCorkindale C, Dyhevik W, et al. Nutritional status of HIV patients during the early stages of the disease. Proceedings of the Fifth International Conference on AIDS; San Francisco, June 21–24, [Abstract] Th.B 200, 1990

  104. Fordyce-Baum MK, Mantero-Atienza E, Van Riel P, et al. Nutritional abnormalities in early HIV: trace elements. Proceedings of the Fifth International Conference on AIDS, Montreal June 4–9, [Abstract Th. B.P. 310]. 1989

  105. Dworkin BD, Rosenthal WA, Wormser GP, et al. Selenium deficiency in AIDS. J Parent Enter Nutr 1986; 10: 405–7

    CAS  Google Scholar 

  106. Colman N, Grossman F. Nutritional factors in epidemic Kaposi’ sarcoma. Semin Oncol 1987; 14 (Suppl.): 54-62

    Google Scholar 

  107. Nelson TA, Wiley CA, Reynolds-Kohler C, et al. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1988; 1: 259–63

    PubMed  CAS  Google Scholar 

  108. Levy JA, Margaretten W, Nelson J. Detection of HIV in en-terochromaffin cells in the rectal mucosa of an AIDS patient. Am J Gastroenterol 1989; 84: 787–92

    PubMed  CAS  Google Scholar 

  109. Adachi A, Koenig S, Gendelman HE, et al. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J Virol 1987; 61: 209–18

    PubMed  CAS  Google Scholar 

  110. Moyer MD, Hout RI, Tamirez A, et al. Infection of human gastrointestinal cells by HIV-1. AIDS Res Human Retrovir 1990; 6: 1409–17

    CAS  Google Scholar 

  111. Barnett SW, Barboza A, Wilcox CM, et al. Characterization of human immunodeficiency virus type 1 strains recovered from bowel of infected individuals. Virology 1991; 182: 802–11

    PubMed  CAS  Google Scholar 

  112. Moyer MP, Hout R, Wideman D, et al. Expression of a potential HIV receptor on human gastrointestinal epithelial cells (giecs). International Conference on AIDS, Montreal 1989 [Abstract], WCP 607

  113. Wang Y, Liang B, Watson RR. Suppression of tissue levels of vitamin A, E, zinc and copper in murine AIDS. Nutr Res 1994. In press

  114. Cunningham-Rundlles S. Effects of nutritional status on immunological function. Am J Clin Nutr 1982; 35: 1202–10

    Google Scholar 

  115. Good RA, Fernandes G, Yunis EJ, et al. Nutritional Deficiency, immunological function and disease. Am J Pathol 1976; 84: 599–614

    PubMed  CAS  Google Scholar 

  116. Colman N, Grossman F. Similarities between AIDS and PCM. Am J Public Med 1983; 73: 1332–9

    Google Scholar 

  117. Eskew ML, Scheuchenzuber WJ. The effects of ozone inhalation on the immunological response of selenium and vitamin E deprived rats. Env Res 1986; 40: 274–84

    CAS  Google Scholar 

  118. Eskew ML, Scholtz RW, Reddy CC, et al. Effects of vitamin E and selenium deficiencies on rat immune function. Immunology 1985; 54: 173–80

    PubMed  CAS  Google Scholar 

  119. Meeker HC, Eskew ML, Scheuchenzuber W, et al. Antioxidant effects of cell-mediated immunity. J Leuk Biol 1985; 38: 451–8

    CAS  Google Scholar 

  120. Bendich A, Gabriel E, Machlin LJ. Protective effect of taurine, zinc and tocopherol on retinol-induced damage in human lymphoblastic cells. Ann NY Acad Sci 1984; 435: 382–4

    CAS  Google Scholar 

  121. Gebremichael A, Levy EM, Corwin LM. Adherent cell requirement for the effect of vitamin E on in vitro antibody synthesis. J Nutr 1984; 114: 1297–305

    PubMed  CAS  Google Scholar 

  122. Huang DS, Wang Y, Marchalonis JJ, et al. Alterations of cytokine production and proliferation in mesenteric lymph nodes caused by LP-BM5 retrovirus infection producing murine AIDS. Regional Immunol 1994. In press

  123. Keen CL, Gershwin ME. Zinc deficiency and immune function. Ann Rev Nutr 1990; 10: 415–31

    CAS  Google Scholar 

  124. Feller LS, Smolin G, Okumoto M, et al. Herpetic keratitis in zinc-deficient rabbits. Invest Ophthalmol Visual Sci 1982; 22: 788–95

    Google Scholar 

  125. Fraker PJ, Caruso R, Kierszenbaum F. Alteration of the immune and nutritional status of mice by synergy between zinc deficiency and infection with Trypanosoma cruzi. J Nutr 1977; 107: 1889–95

    PubMed  CAS  Google Scholar 

  126. Fenwick PK, Aggett PJ, Macdonald DC, et al. Zinc deprivation and zinc repletion: effect on the response of rats to infection with Trichinella spiralis. Am J Clin Nutr 1990; 52: 166–72

    PubMed  CAS  Google Scholar 

  127. Fenwick PK, Aggett PJ, Macdonald DC, et al. Zinc deprivation and zinc repletion: effect on the response of rats to infection with Strongyloides ratti. Am J Clin Nutr 1990; 52: 173–7

    PubMed  CAS  Google Scholar 

  128. Pedroni E, Baianchi E, Ugazio AG, et al. Immunodeficiency and steely hair. Lancet 1975; 1: 1303–4

    PubMed  CAS  Google Scholar 

  129. Graham GG, Cordano A. Copper depletion and deficiency in the malnourished infant. Johns Hopkins Med J 1969; 124: 139–50

    PubMed  CAS  Google Scholar 

  130. Al-Rashid RA, Spangler J. Neonatal copper deficiency. N Eng J Med 1971; 285: 841–3

    CAS  Google Scholar 

  131. Yuen P, Lin HJ, Hutchison JH. Copper deficiency in a low birth weight infant. Arch Dis Child 1979; 54: 553–5

    PubMed  CAS  Google Scholar 

  132. Boyne R, Arthur JR. Effects of selenium and copper deficiency on neutrophil function in cattle. J Comp Pathol 1981; 91: 271–6

    PubMed  CAS  Google Scholar 

  133. Jones DG, Suttle NF. Some effects of copper deficiency on the resistance of mice to infection with Pasteurella haemolytica. J Comp Pathol 1983; 93: 143–9

    PubMed  CAS  Google Scholar 

  134. Jones DG, Suttle NF. Some effects of copper on leukocyte function in sheep and cattle. Res Vet Sci 1981; 31: 151–6

    PubMed  CAS  Google Scholar 

  135. Prohaska JR, Lukaewycz OA. Copper deficiency suppresses the immune response in mice. Sciences 1981; 213: 559–61

    CAS  Google Scholar 

  136. Lukasewycz OA, Prohaska JR. Lymphocytes from copper-deficient mice exhibit decreased mitogen reactivity. Nutr Res 1983; 3: 335–41

    CAS  Google Scholar 

  137. Lukasewycz OA, Prohaska JR, Meyer SG, et al. Alterations in lymphocytes subpopulations in copper deficient mice. Infect Immunol 1985; 48: 644–7

    CAS  Google Scholar 

  138. Prohaska JR, Kolquist KL, Lukaewycz OA. Splenocytes from copper-deficient mice are low responders and weak simulators in mixed lymphocytes reaction. Nutr Res 1987; 7: 43–52

    Google Scholar 

  139. Lukasewycz OA, Prohaska JR. Immunization against transplantable leukemia impaired in copper-deficient mice. J Natl Cancer Inst 1982; 69: 489–93

    PubMed  CAS  Google Scholar 

  140. Bendich A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr 1988; 48: 612–9

    PubMed  CAS  Google Scholar 

  141. Machlin LJ, Vitamin E. In: Machlin LJ, editor. Handbook of vitamins: nutritional, biochemical, and clinical aspects. New York, NY: Marcel Dekker Inc. 1984; 100-45

  142. Federation of American Societies for Experimental Biology (FASEB). Evaluation of the health aspects of tocopherols and α-tocopherol acetate as food ingredients. Washington, DC: FASEB, 1975

  143. Committee on Dietary Allowances, Food and Nutrition Board, National Research Council. Recommended dietary allowances. 10th ed. Washington DC: National Academy Press, 1989

  144. Shoulson I. Deprenyl and tocopherol antioxidative therapy of Parkinsonism (DATATOP) Parkinson Study Group. Acta Neurol Scad Suppl 1989; 126: 171–5

    CAS  Google Scholar 

  145. The Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med 1989; 321: 1364–71

    Google Scholar 

  146. Moseson M, Zeleniuch-Jacquotte A, Belsito DV, et al. The potential role of nutritional factors in the induction of immunological abnormalities in HIV-positive homosexual men. J AIDS 1989; 2: 235–47 149. Mino M. Use and safety of elevated dosages of vitamin E in infants and children. Int J Vitam Nutr Res Suppl. 1989; 30: 69-80

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family and Community Medicine and Nutritional Sciences Program, University of Arizona, Tucson, Arizona, AZ 85724, USA

    Yuejian Wang & Ronald Ross Watson

Authors
  1. Yuejian Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronald Ross Watson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Watson, R.R. Potential Therapeutics of Vitamin E (Tocopherol) in AIDS and HIV. Drugs 48, 327–338 (1994). https://doi.org/10.2165/00003495-199448030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199448030-00001

Keywords

Search

Navigation